Axoft Raises $55M Oversubscribed Series A For Ultra-Soft Brain Implants

April 29, 2026 | Startups | ,

Neurotech startup Axoft secures an oversubscribed $55 million Series A to fast-track clinical trials and FDA clearance of its revolutionary Fleuron™.